News

Bluefors welcomes Kim Povlsen as New Chief Executive Officer

Mikko Heinonen appointed as a Member of the Board of Directors of DevCo Partners

DevCo’s sustainability report 2024 published

Medix Biochemica Expands its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring CANDOR Bioscience

Vexve strengthens its leading position in hydronic networks by acquiring Danish valve manufacturer Frese A/S

DevCo strengthens its team – Petteri Tuominen to join as Investment Professional

DevCo Appoints Matias Karioja as Partner

DevCo closes a 616 MEUR long-term single-asset investment vehicle for Medix Biochemica

DevCo Partners’ application period for 2025 internships is now open

Medix Biochemica Appoints Lonnie Shoff, Seasoned Healthcare Executive to its Board of Directors

DevCo strengthens its team – Otto Saaranto to join as Investment Professional

Sustainability report for 2023 is published

DevCo strengthens its team – Timo Ihamuotila new Senior Advisor

Vexve Armatury Group companies join their forces under the Vexve brand

Vexve Armatury Group Appoints Paul Gustavsson as New Chief Executive Officer

Medix Biochemica expands its infectious diseases antibody offering through the acquisition of ViroStat

Jonas Geust Becomes Bluefors CEO

Linda Pålsson Appointed as Non-executive Director at Vexve Armatury Group Oy

DevCo Partners’ application period for 2024 internships is now open

Bluefors to acquire its distributor Rockgate, establishing direct presence in the Japanese cryogenics technology market

Bluefors to acquire Cryomech, creating a global leader in the ultra-low temperature cooling technology market

Bluefors’ technology featured on the cover of TIME magazine

Nick Adcock Appointed as Non-executive Director at Vexve Armatury Group Oy

Medix Biochemica Appoints Dr. Michele Pedrocchi to its Board of Directors

DevCo strengthens its team – Lennart Sjöblom to join as Investment Professional and Heli Leskinen as CFO

Medix Biochemica broadens its capabilities in diagnostic base matrices through the acquisition of Bioresource Technology

Vexve Armatury Group strengthens its position in DACH region by acquiring Armatury Group GmbH

Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec

DevCo closes its next long-term single-asset fund at €260m

DevCo strengthens its team – Vanechka Patel new Investment Professional

DevCo strengthens its team – Outi Saari new Investment Professional

Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone

Kari Lehtinen appointed as the new Chairman of the Board of Vexve Armatury Group

DevCo strengthens its team – Heini Mänttäri new Investment Professional

DevCo’s partner and Chairman Matti Alahuhta joins the board of Kasvuryhmä

DevCo to support Bluefors’ next growth phase

DevCo strengthens its team – Vella Kimpimäki new Finance Manager

Article by DevCo's Otto Kukkonen featured in Yrityskatsaus magazine of The Ministry of Economic Affairs and Employment in Finland

Column by Teemu Alahuhta featured in Perheyrityslehti

Kari Lehtinen and Markku Simula Appointed as Non-executive Directors at Vexve Armatury Group

DevCo continues as a business partner for Family Business Network Finland at least until 2022

Vexve Armatury Group strengthens its position in petrochemical sector by acquiring German specialized valve supplier ZMK Technologies GmbH

Medix Biochemica expands to Drugs of Abuse antibody and antigen manufacturing through acquisition of Biostride Inc.

Medix Biochemica broadens product portfolio and further expands U.S. presence through acquisition of EastCoast Bio

DevCo launches DevCo Academy - a top management training program

Vexve Armatury Group featured in Kauppalehti

Medix Biochemica expands to biomaterials for IVD industry through acquisition of Lee Biosolutions

DevCo Partners strengthens its investor base by raising €180m of long-term commitments for its next platform investment

Steve Ferguson appointed new CEO of Medix Biochemica

DevCo has signed an agreement to acquire the leading Czech industrial valve manufacturer ARMATURY Group

Medix Biochemica participates in the Annual Scientific Meeting & Clinical Lab Expo

DevCo strengthens its team – Juhani Laakso new Partner

DevCo featured in Perheyrityslehti

What to take into account during a generational change at a company?

Building new Finnish large companies ”Uusia suomalaisia suuryrityksiä rakentamassa”

DevCo strengthens its team – Johannes Vanne new Associate

DevCo Partners to accelerate growth of Medix Biochemica

DevCo strengthens its team – Matias Karioja new Associate

DevCo Partners to accelerate growth of Vexve

DevCo Partners strengthens its investor base

Devco Partners to support growth of medium-sized companies